Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0L7SK
|
|||
| Drug Name |
PMID26924192-Compound-30
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
KYORIN PHARMACEUTICAL CO., LTD
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C33H41N7O3
|
|||
| Canonical SMILES |
CCOC1=C(C=CC(=C1)C(=O)N2CCC(C2)NC3CCN(CC3)C)NC4=NC=C5C(=C4)N(C6=CC=CC=C6C(=O)N5C)C
|
|||
| InChI |
1S/C33H41N7O3/c1-5-43-30-18-22(32(41)40-17-14-24(21-40)35-23-12-15-37(2)16-13-23)10-11-26(30)36-31-19-28-29(20-34-31)39(4)33(42)25-8-6-7-9-27(25)38(28)3/h6-11,18-20,23-24,35H,5,12-17,21H2,1-4H3,(H,34,36)/t24-/m0/s1
|
|||
| InChIKey |
SXKDARBSSREUSH-DEOSSOPVSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Bromodomain-containing protein 4 (BRD4) | Target Info | Inhibitor | [1] |
| Extracellular signal-regulated kinase 5 (ERK5) | Target Info | Inhibitor | [1] | |
| Target's Patent Info | Bromodomain-containing protein 4 (BRD4) | Target's Patent Info | [1] | |
| Extracellular signal-regulated kinase 5 (ERK5) | Target's Patent Info | [1] | ||
| WikiPathways | Chemical Compounds to monitor Proteins | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | BET inhibitors in cancer therapeutics: a patent review.Expert Opin Ther Pat. 2016;26(4):505-22. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.